Prelude Therapeutics had a revenue of 6.50M in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 10.50M, Decreased 50.00%. In the fiscal year ending Dec 31, 2024, Prelude Therapeutics had annual revenue of 7.00M with Infinity% growth.